Type 2 diabetes
Clinical features
- This form of diabetes most often occurs after the age of 40 so it has been referred to as maturity-onset
diabetes.
Genetics
- Genetic predisposition for type 2 diabetes is stronger than for type 1, but the magnitude of genetic
contribution is unknown and probably involves several genes. - Recent research has identified that several polymorphisms in the hepatocyte nuclear factor 4 alpha
(HNF-4α) gene is associated with increased susceptibility to type 2 diabetes by about 30%. - Genetic testing is still in the research phase.
Prevalence
- 7.5% of the Australian population aged 25 years and older have diabetes, 8.0% of males and 7.0% of females. In people 75 years and over, 23.6% has diabetes.
- Type 2 diabetes accounts for more than 85% of people with diabetes in Australia.
- Increasing incidence of diabetes parallels the increase incidence of obesity.
- The frequency of the condition, and the most common age of onset, is different in different populations.
The condition is epidemic in some countries. - The lowest prevalences are seen in less developed countries (up to 2% in China and Africa).
- The highest prevalence can be found in certain ethic groups around the world:
- Greater than 50% prevalence in Australian Aboriginal people.
- Increased prevalences of diabetes in Pima Indians in the USA, South Sea Islanders and Pacific
Islanders, all of whom develop type 2 diabetes early in their lives and quite severely.
Management
- For at-risk family members, diet and exercise may postpone the onset of the condition, or diabetes may
not develop at all.
Implications for family members
- Risk that relatives of a family member with type 2 diabetes will also develop the condition has been
estimated from observations of families with a history of the condition, not genetic testing (Table 2).
Table 2
Approximate genetic risks in type 2 diabetes mellitus (European data)



